Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
GRAIL, a member of Bio Nebraska, has been acquired by Illumina, the global leader in DNA sequencing. GRAIL will continue to operate as a separate company. Read more